ASP Isotopes Inc. (ASPI) stock is soaring 13.59% in pre-market trading on Friday, following the announcement of a significant $22 million loan agreement with TerraPower, a leading U.S. nuclear innovation firm. This surge builds upon the gains seen in the previous trading session, as investors react positively to the company's strategic move in the nuclear energy sector.

The loan agreement, signed on May 16, 2025, outlines TerraPower's commitment to provide conditional financial support to ASP Isotopes' subsidiary, QLE TP Funding SPE LLC. The funds are earmarked for the construction of a new uranium enrichment facility, specifically for the production of High Assay Low-Enriched Uranium (HALEU), a crucial component for advanced nuclear reactors. The loan, guaranteed by ASP Isotopes Inc. and Quantum Leap Energy LLC, carries a maturity date of May 16, 2032, providing a long-term financial framework for the project.

Investors are showing strong enthusiasm for this development, viewing it as a significant step forward for ASP Isotopes' growth and market position in the nuclear energy industry. The deal not only provides substantial financial backing but also includes a long-term supply arrangement that allows ASP Isotopes to sell excess HALEU to other buyers if TerraPower doesn't meet certain purchase criteria. This flexibility, combined with the partnership with a leading player in the nuclear industry, has bolstered confidence in ASP Isotopes' future prospects in the growing market for advanced nuclear fuel. The impressive pre-market performance reflects growing optimism about the company's potential to capitalize on opportunities in the evolving nuclear energy landscape.